Company research / RKDA

Arcadia Biosciences, Inc. (RKDA)

CIK 0001469443 · Nasdaq · Crude Petroleum & Natural Gas

  • Sector Mining
  • Incorporated DE
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, Arcadia Biosciences, Inc. reported revenue of $4.86M. Revenue fell 3.7% from the prior annual period.

Key ratios (year ended 2025-12-31)

-51.5%
Operating margin
-48.1%
Net margin
-56.5%
Return on year-end equity
-3.7%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: 8-K · 2026-09-04

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. A dash means a matching observation is unavailable.